Peter Roy-Byrne

2 months ago | jwatch.org | Peter Roy-Byrne

Jan 24, 2025 | digitalcommons.library.tmc.edu | Jonas Bybjerg-Grauholm |Peter Roy-Byrne |Caroline M Nievergelt |Adam X. Maihofer

KeywordsHumans, Genetic Loci, Genetic Predisposition to Disease, Genome-Wide Association Study, Neurobiology, Polymorphism, Single Nucleotide, Stress Disorders, Post-Traumatic, White People, White, Black or African American, American Indian or Alaska NativeAbstractPost-traumatic stress disorder (PTSD) genetics are characterized by lower discoverability than most other psychiatric disorders. The contribution to biological understanding from previous genetic studies has thus been limited.

Jan 14, 2025 | jwatch.org | Peter Roy-Byrne

Jan 7, 2025 | jwatch.org | Peter Roy-Byrne

Peter Roy-Byrne, MD Treating patients with trauma-related distress might turn out to be the preferred application for this drug. Psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, initially was proposed as an adjunct to enhance psychotherapy in the early 1960s, before psychedelic use was outlawed.

Oct 3, 2024 | jwatch.org | Peter Roy-Byrne

Peter Roy-Byrne, MD, reviewing rTMS augmentation of antidepressants might be comparable to medication augmentation and is superior to switching to another single antidepressant. Repetitive transcranial magnetic stimulation (rTMS) can be effective in depressed patients who don't respond to initial antidepressant drug therapy. In these two randomized trials, researchers explored its efficacy - compared with traditional next-step interventions - in nonresponders to two different antidepressants.